Antimicrobial activity and synergism of some substituted flavonoids

Folia Microbiologica

Volumn 53, Issue 1, 2008, Pages 23-28

  Alvarez, M A ^a   Debattista, N B ^a   Pappano, N B ^a  

^a UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; FLAVONOID;

ARTICLE; CELL MEMBRANE; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGICAL EXAMINATION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CELL MEMBRANE; DRUG SYNERGISM; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; FLAVONOIDS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); ENTEROBACTER AEROGENES; ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 43749102029     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-008-0003-4     Document Type: Article

References (34)

1. Alvarez M.A., Zarelli V.E.P., Pappano N.B., Debattista N.B.: Bacteriostatic action of synthetic polyhydroxylated chalcones against Escherichia coli. Biocell 28, 31-34 (2004).
2. Alvarez M.A., Debattista N.B., Pappano N.B.: Synergism of flavonoids with bacteriostatic action against Staphylococcus aureus ATCC 25 923 and Escherichia coli ATCC 25 922. Biocell 30, 39-42 (2006).
3. Bavoil P., Nikaido H.: Pleiotropic transport mutants of Escherichia coli tack porin, a major outer membrane protein. Mol.Gen.Genet. 158, 23-33 (1977).
4. Bornet C., Davin-Regli A., Bosi C., Pages J.-M., Bollet C.: Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability. J.Clin.Microbiol. 38, 1048-1052 (2000).
5. Brooks G., Butel J., Ornoston N.: Microbiología Médica (E. Jawetz, J.L. Melnick, J.L. Adelberg, Eds). México (DF) 1996.
6. Charrel R.N., Pages J.-M., Micco P., Mallea M.: Prevalence of outer membrane porin alteration in β-lactam-antibiotic-resistant Enterobacter aerogenes. Antimicrob.Agents Chemother. 40, 2854-2858 (1996).
7. Chen D.P., Tang J., Eisenberg R.S.: Structure-function study of porins. Nanotechnologies 2, 64-67 (2002).
8. Chiang L.C., Chiang W., Liu M.C., Lin C.C.: In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids. J.Antimicrob.Chemother. 52, 194-198 (2003).
9. Devia C.M., Pappano N.B., Debattsta N.B.: Structure-biological relationship of synthetic trihydroxylated chalcones. Rev.Microbiol. 29, 307-310 (1998).
10. Dhar D.N.: The Chemistry of Chalcones and Related Compounds, pp. 5-9. John Wiley & Sons, New York 1981.
11. Favier L.S., Nieto M., Giordano O.S., Tonn C.E.: Diterpenoids and flavonoids from Ophryosporus charrua. Phytochemistry 45, 1469-1474 (1997).
12. Goniotaki M., Hatziantoniou S., Dimas K., Wagner M., Demetzos C.: Encapsulation of naturally occurring flavonoids into liposomes: physicochemical properties and biological activity against human cancer cell lines. J.Pharm.Pharmacol. 56, 1217-1224 (2004).
13. Hancock R.E.W.: Role of porins in outer membrane permeability. J.Bacteriol. 169, 929-933 (1987).
14. Hirano T., Arimitsu J., Higa S., Naka T., Ogata A., Shima Y., Fujimoto M., Yamadori T., Ohkawara T., Kuwabara Y., Kawai M., Kawase I., Tanaka T.: Luteolin, a flavonoid, inhibits CD40 ligand expression by activated human basophils. Internat.Arch.Allergy Immunol. 140, 150-156 (2006).
15. Inoue T., Sugimoto Y., Masuda H., Kamei C.: Antiallergic effect of flavonoid glycosides obtained from Mentha piperita L. Biol. Pharm.Bull. 25, 256-259 (2002).
16. Li J.X., Xue B., Chai Q., Liu Z.X., Zhao A.P., Chen L.B.: Antihypertensive effect of total flavonoid fraction of Astragalus complanatus in hypertensive rats. Chin.J.Physiol. 48, 101-106 (2005).
17. López-Lázaro M.: Flavonoids as anticancer agents: structure-activity relationship study. Curr.Med.Chem.Anticancer Agents 2, 691-714 (2002).
18. Mallea M., Chevallier J., Bornet C., Eyraud A., Davin-Regli A., Bollet C., Pages J.-M.: Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology 144, 3003-3009 (1998).
19. Martini N.D., Katerere D.R.P., Eloff J.N.: Biological activity of five antibacterial flavonoids from Combretum erythrophyllum (Combretaceae). J.Etnopharmacol. 93, 207-212 (2004).
20. Meragelman T.L., Tucker K.D., McCloud T.G., Cardellina J.H., Shoemaker R.H.: Antifungal flavonoids from Hildegardia barteri. J.Nat.Prod. 68, 1790-1792 (2005).
21. 2-sensitized photo-oxidation of structurally related dihydroxyflavonoids. Dyes & Pigments 58, 113-120 (2003a).
22. Montaña M.P., Pappano N.B., Debattista N.B., Avila V., Posadaz A., Bertolotti S.G., Garcia N.A.: The activity of 3-and 7-hydroxyflavones as scavengers of superoxide radical anion generated from photo-excited riboflavin. Can.J.Chem. 81, 909-914 (2003b).
23. Mutalik S., Paridhavi K., Mallikarjuna Rao C., Udupa N.: Antipyretic and analgesic effect of leaves of Solanum melongena L. in rodents. Indian J.Pharmacol. 35, 312-315 (2003).
24. Nay B., Collet M., Lebon M., Cheze C., Vercauteren J.: Methods in synthesis of flavonoids. Part 3: Molybdenum(IV)-catalyzed coupling of cinnamyl alcohols to phenol derivatives. Tetrahedron Lett. 43, 2675-2678 (2002).
25. Olivella M.S., Zarelli V.E.P., Pappano N.B., Debattista N.B.: A comparative study of bacteriostatic activity of synthetic hydroxylated flavonoids. Brazil.J.Microbiol. 32, 229-232 (2001).
26. Pages J.M.: Porines bactériennes et sensibilité aux antibiotiques. Med.Sci. 20, 346-351 (2004).
27. Pappano N.B., Centorbi O.P., Ferretti F.H.: Determinación de la concentración mínim a inhibitoria a partir de parámetros cinéticos de crecimiento. Rev.Microbiol. 21, 183-188 (1990).
28. Pappano N.B., Centorbi O.P., Ferretti F.H.: Determination of the responsible molecular zone for the chalcones bacteriostatic activity. Rev.Microbiol. 25, 168-174 (1994).
29. Purnima A., Prasanna G.S., Mathuram V.: Analgesic and anti-inflammatory activity of the chloroform extract of Trichilia connaroides (W. & A.) bentilizen. Indian J.Pharm.Sci. 68, 231-233 (2006).
30. Reshe N., Hayari Y., Goren C., Boaz M., Madar Z., Knobler H.: Antihypertensive effect of sweetie fruit in patients with stage I hypertension. Am.J.Hypertension 18, 1360-1363 (2005).
31. Wang Y.F., Dutzler R., Rizkañah P.J., Rosenbuch J.P., Schirmer T.: Channel specificity: structural basis for sugar discrimination and differential flux rates in maltoporin. J.Mol.Biol. 272, 56-63 (1997).
32. Yang Y.C., Lu F.H., Wu J.S., Wu C.H., Chang C.J.: The protective effect of habitual tea consumption on hypertension. Arch.Intern.Med. 164, 1534-1540 (2004).
33. Yppolito R., Pappano N., Debattista N., Miskoski S., Bertolotti S., Garcia N.: On the antioxidant properties of therapeutics drugs: quenching of singlet molecular oxygen by amino-salicylic acids. Redox Report. 7, 43-47 (2002).
34. Zakay-Rones Z., Thom E., Wollan T., Wadstein J.: Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J.Intern.Med.Res. 32, 132-140 (2004).